- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sonoma Pharmaceuticals Inc (SNOA)
Assess today's live Sonoma Pharmaceuticals Inc (SNOA) share price, performance and insights using our live NASDAQ: SNOA stock exchange data.
Analyse the historical data and Sonoma Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Sonoma Pharma share price buy/sell indicators using real-time data (or discuss the Sonoma Pharma (SNOA) stock price today with other investors in the Sonoma Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SNOA share price (ISIN: US83558L3033) to enhance your trading decisions with our free investment tools and resources.
What Is the Sonoma Pharmaceuticals Inc Share Price Today?
The Sonoma Pharma share price today is 3.270.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc
The stock symbol (or 'ticker') for Sonoma Pharmaceuticals Inc is "SNOA."
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Sonoma Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Sonoma Pharma share price buy/sell indicators using real-time data (or discuss the Sonoma Pharma (SNOA) stock price today with other investors in the Sonoma Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SNOA share price (ISIN: US83558L3033) to enhance your trading decisions with our free investment tools and resources.
What Is the Sonoma Pharmaceuticals Inc Share Price Today?
The Sonoma Pharma share price today is 3.270.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc
The stock symbol (or 'ticker') for Sonoma Pharmaceuticals Inc is "SNOA."
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.260
3.320
52 wk Range
1.750
6.920
SNOA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2603.320
52 wk Range
1.7506.920
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SNOA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
13.400
Upside
+309.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Sonoma Pharmaceuticals Inc For: 2 January
- Investing.com
- Form 8K Sonoma Pharmaceuticals Inc For: 2 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Sonoma Pharma Company Profile
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.
Compare SNOA to Peers and Sector
Metrics to compare | SNOA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNOAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | 11.4x | −0.6x | |
PEG Ratio | −0.03 | 0.22 | 0.00 | |
Price/Book | 1.5x | 3.3x | 2.6x | |
Price / LTM Sales | 0.3x | 2.6x | 3.4x | |
Upside (Analyst Target) | 309.8% | 115.1% | 42.5% | |
Fair Value Upside | Unlock | 14.2% | 5.8% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.400
(+309.79% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
-0.32 / -0.05
Revenue / Forecast
5.60M / 5.24M
People Also Watch
FAQ
What Is the Sonoma Pharma (SNOA) Share Price Today?
The live Sonoma Pharma share price today is 3.270
What Stock Exchange Does Sonoma Pharma (SNOA) Trade On?
Sonoma Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Sonoma Pharma?
The stock symbol (also called a 'ticker') for Sonoma Pharma is "SNOA."
What Is the Current Sonoma Pharma Market Cap?
As of today, Sonoma Pharma market capitalisation is 5.56M.
What Is Sonoma Pharma's (SNOA) Earnings Per Share (TTM)?
The Sonoma Pharma EPS is currently -2.19 (Trailing Twelve Months).
Is SNOA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sonoma Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sonoma Pharma Stock Split?
Sonoma Pharma has split 4 times. (See the SNOA stock split history page for full effective split date and price information.)
How Many Employees Does Sonoma Pharma Have?
Sonoma Pharma has 8 employees.
What is the current trading status of Sonoma Pharma (SNOA)?
As of 22 Jan 2026, Sonoma Pharma (SNOA) is trading at a price of 3.270, with a previous close of 3.270. The stock has fluctuated within a day range of 3.260 to 3.320, while its 52-week range spans from 1.750 to 6.920.
What Is Sonoma Pharma (SNOA) Price Target According to Analysts?
The average 12-month price target for Sonoma Pharma is USD13.400, with a high estimate of USD14.8 and a low estimate of USD12. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +309.79% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.